Xuefen Li

1.1k total citations
47 papers, 846 citations indexed

About

Xuefen Li is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Xuefen Li has authored 47 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 17 papers in Hepatology and 12 papers in Immunology. Recurrent topics in Xuefen Li's work include Hepatitis B Virus Studies (22 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). Xuefen Li is often cited by papers focused on Hepatitis B Virus Studies (22 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). Xuefen Li collaborates with scholars based in China, Hong Kong and United States. Xuefen Li's co-authors include Yu Chen, Yuejiao Dong, Xia Liu, Haishen Kong, Yu Chen, Li Tian, Lanjuan Li, Qiaoyun Zhu, Yiyin Wang and Weili Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Xuefen Li

44 papers receiving 832 citations

Peers

Xuefen Li
Maria C. Villacres United States
K Madaliński Poland
Angela Rohwedder Germany
Alec E. Wittek United States
Gustavo Gonzalez-Canali France
Tanja Jovanović Serbia
P. E. Taylor United States
Zabihollah Shoja Iran
Andrew Berical United States
Maria C. Villacres United States
Xuefen Li
Citations per year, relative to Xuefen Li Xuefen Li (= 1×) peers Maria C. Villacres

Countries citing papers authored by Xuefen Li

Since Specialization
Citations

This map shows the geographic impact of Xuefen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefen Li more than expected).

Fields of papers citing papers by Xuefen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefen Li. The network helps show where Xuefen Li may publish in the future.

Co-authorship network of co-authors of Xuefen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefen Li. A scholar is included among the top collaborators of Xuefen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefen Li. Xuefen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jianyun, Ming Ma, Xuefen Li, et al.. (2025). Identification of Novel and Rare GNAS Mutations in Craniofacial Fibrous Dysplasia. Journal of Oral Pathology and Medicine. 54(2). 120–125.
2.
3.
Yang, Jiezuan, et al.. (2024). CXCL10 and its receptor in patients with chronic hepatitis B and their ability to predict HBeAg seroconversion during antiviral treatment with TDF. Journal of Medical Virology. 96(3). e29516–e29516. 1 indexed citations
4.
Yang, Jiezuan, Dan Cao, Ruiqi Tang, & Xuefen Li. (2024). Chemokines and Their Receptors in Hepatitis B Virus Infection: A Comprehensive Review. 6(4). 171–181.
5.
Li, Yongtao, et al.. (2023). Profile and clinical significance of interferon gamma-inducible protein-10 (IP-10) and its receptor in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 149(16). 14879–14888. 4 indexed citations
6.
Li, Xuefen, et al.. (2023). JNK/c‐Jun pathway activation is essential for HBx‐induced IL‐35 elevation to promote persistent HBV infection. Journal of Clinical Laboratory Analysis. 37(5). e24860–e24860. 4 indexed citations
7.
Li, Xuefen, Xia Liu, & Weilin Wang. (2021). IL-35: A Novel Immunomodulator in Hepatitis B Virus-Related Liver Diseases. Frontiers in Cell and Developmental Biology. 9. 614847–614847. 12 indexed citations
8.
Zhang, Ludan, Qian Zhang, Ning Du, et al.. (2020). Antimicrobial Activity of an Implantable Wireless Blue Light-Emitting Diode Against Root Canal Biofilm In Vitro. Photobiomodulation Photomedicine and Laser Surgery. 38(11). 694–702. 5 indexed citations
9.
Dong, Yuejiao, Xuefen Li, Lu Zhang, et al.. (2019). CD4+ T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B. BMC Immunology. 20(1). 27–27. 93 indexed citations
10.
Li, Xuefen, Yuejiao Dong, Xianzhi Yang, et al.. (2018). Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses. Vaccine. 36(18). 2442–2449. 15 indexed citations
11.
Kong, Haishen, Fei Yu, Weili Zhang, Xuefen Li, & Hongxia Wang. (2017). Molecular Epidemiology and Antibiotic Resistance Profiles of Methicillin-Resistant Staphylococcus aureus Strains in a Tertiary Hospital in China. Frontiers in Microbiology. 8. 838–838. 22 indexed citations
12.
Ye, Bo, Xuefen Li, Yuejiao Dong, et al.. (2017). Increasing LAG-3 expression suppresses T-cell function in chronic hepatitis B. Medicine. 96(1). e5275–e5275. 30 indexed citations
13.
Fan, Jian‐Gao, Siu-Ying Lau, Guoliang Xie, et al.. (2014). Detection of a novel avian influenza A (H7N9) virus in humans by multiplex one-step real-time RT-PCR assay. BMC Infectious Diseases. 14(1). 541–541. 16 indexed citations
14.
Li, Xuefen, Xia Liu, Li Tian, & Yu Chen. (2014). Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections. Clinical Reviews in Allergy & Immunology. 50(1). 41–54. 83 indexed citations
15.
Li, Xuefen, Yiyin Wang, & Yu Chen. (2014). Cellular immune response in patients with chronic hepatitis B virus infection. Microbial Pathogenesis. 74. 59–62. 21 indexed citations
16.
Shi, Ruirui, Xuefen Li, Ran Zhang, Yan Chen, & Tiejun Li. (2013). GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw. Modern Pathology. 26(8). 1023–1031. 52 indexed citations
17.
Kong, Haishen, et al.. (2013). Combined use of the BinaxNOW Staphylococcus aureus test with the Clearview PBP2a assay for the early detection of methicillin-resistant S. aureus from positive blood cultures. Diagnostic Microbiology and Infectious Disease. 78(3). 226–228. 11 indexed citations
18.
Li, Xuefen. (2012). Retrospective analysis of TORCH test in Bazhong area during 2009-2011. 1 indexed citations
19.
Ye, Bo, et al.. (2010). Retrospective analysis of hepatitis B virus serological markers in 70 582 inpatients. Zhonghua jianyan yixue zazhi. 33(10). 918–923. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria C. Villacres Breakdown of academic impact, for papers by K Madaliński Breakdown of academic impact, for papers by Angela Rohwedder Breakdown of academic impact, for papers by Alec E. Wittek Breakdown of academic impact, for papers by Gustavo Gonzalez-Canali Breakdown of academic impact, for papers by Tanja Jovanović Breakdown of academic impact, for papers by P. E. Taylor Breakdown of academic impact, for papers by Zabihollah Shoja Breakdown of academic impact, for papers by Andrew Berical
Rankless by CCL
2026